Assessing the Impact of Interstudy Variation in LOAELs on Findings of Low-Dose Additivity in In Vivo Studies of Mixtures

Demonstrating the safe use of chemical mixtures remains a critical challenge in toxicological science. In recent years, studies have suggested that chemicals can exhibit dose additivity—causing a combined effect—even when each chemical individually is below its effect threshold. This project was initiated to investigate whether interstudy variation in Lowest Observed Adverse Effect Levels (LOAELs) might account for some of these findings, particularly in animal studies employing the serial-dilution study design.

Building on published findings by EPA researchers, the client sought to explore whether variability in LOAELs across studies could result in observable effects in mixtures that do not actually follow dose addition principles. The scope included reviewing and refining existing uncertainty estimates in LOAELs and other points of departure (PODs), analyzing known sources of interstudy variability, and developing quantitative models to assess these uncertainties. Additional objectives involved assessing the influence of using alternative PODs such as Benchmark Doses (BMDs) and No Observed Adverse Effect Levels (NOAELs), and exploring how mixed mechanisms of action within chemical groups could alter observed responses.

The client also expressed interest in comparing the implications of these findings to results from specific studies, notably one by Wolansky et al. (2005), which may be pursued as a follow-on project. Overall, the work aims to improve interpretation of low-dose effects in mixture toxicity studies and support more robust regulatory decision-making.